Quarterly report pursuant to Section 13 or 15(d)

Capital Transactions (Details)

v2.4.0.6
Capital Transactions (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
1 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2012
May 31, 2012
Sep. 30, 2012
Sep. 30, 2012
Sep. 30, 2012
Stock options
Dec. 31, 2011
Stock options
Sep. 30, 2012
Stock options
Minimum
Sep. 30, 2012
Stock options
Maximum
Sep. 30, 2012
Time-based stock options
Sep. 30, 2011
Time-based stock options
Sep. 30, 2012
Time-based stock options
Sep. 30, 2011
Time-based stock options
Dec. 31, 2011
Time-based stock options
Sep. 30, 2012
Time-based stock options
Maximum
Sep. 30, 2012
Operating income performance-based stock options
Sep. 30, 2011
Operating income performance-based stock options
Sep. 30, 2012
Operating income performance-based stock options
Sep. 30, 2011
Operating income performance-based stock options
Dec. 31, 2011
Operating income performance-based stock options
Sep. 30, 2012
Net sales revenue performance-based stock options
Sep. 30, 2012
Net sales revenue performance-based stock options
Minimum
Sep. 30, 2012
Net sales revenue performance-based stock options
Maximum
Sep. 30, 2012
Restricted stock unit
Sep. 30, 2012
Restricted stock unit
Sep. 30, 2012
2009 Incentive Plan
Maximum
Sep. 30, 2012
2009 Incentive Plan
Stock options
Sep. 30, 2012
2009 Incentive Plan
Time-based stock options
Sep. 30, 2012
2012 Incentive Plan
Sep. 30, 2012
2012 Incentive Plan
Stock options
Dec. 31, 1995
1995 Stock Plan
Maximum
Dividends [Abstract]                                                            
Cash Dividend per common share (in dollars per share) $ 0.05 $ 0.05 $ 0.05 $ 0.10                                                    
Dividend paid $ 780 $ 780                                                        
Share-based Compensation                                                            
Number of shares authorized                                                 400     1,500    
Expiration period                                                   10 years     10 years 10 years
Number of shares                                                            
Options outstanding at the beginning of the period (in shares)         1,374                                                  
Granted (in shares)         681                                           217   464  
Expired (in shares)         (6)                                                  
Exercised (in shares)         (191)                                                  
Options outstanding at the end of the period (in shares)         1,858                                                  
Weighted Average Exercise Price Per Share                                                            
Options outstanding at the beginning of the period (in dollars per share)         $ 9.88                                                  
Granted (in dollars per share)         $ 15.11                                         $ 15.65     $ 14.86  
Expired (in dollars per share)         $ 8.59                                                  
Exercised (in dollars per share)         $ 10.34                                                  
Options outstanding at the end of the period (in dollars per share)         $ 11.75                                                  
Share-based compensation, additional disclosures                                                            
Vesting period                           48 months                   1 year            
Operating income margin, one (as a percent)                                 6.00%                          
Operating income margin, two (as a percent)                                 8.00%       8.00%                  
Operating income margin, three (as a percent)                                 10.00%                          
Period of time during which operating income margins must be achieved in order to vest in performance based stock options                                 12 months                          
Consecutive period of time used to assess operating income margins which determine vesting                     15 months                                      
Period of cumulative net sales revenue growth                                       2 years                    
Weighted-average grant date fair value (in dollars per share)                                                   $ 7.66     $ 7.01  
Weighted-average assumptions used to calculate fair value of options granted                                                            
Expected life             4 years 6 years                                            
Risk-free interest rate (as a percent)             0.30% 0.90%                                            
Expected volatility (as a percent)             58.50% 66.00%                                            
Dividend yield (as a percent)             0.00% 1.30%                                            
Share-based compensation, related information                                                            
Share-based compensation expense                 630 166 1,299 390     0 607 652 1,527         50 50            
Related tax benefits                 246 66 513 156     0 240 255 603         20 20            
Unrecognized share-based compensation expense                 3,285   3,285   607   0   0   652       173 173            
Expense expected to be recognized over a weighted-average period                     1 year 10 months 24 days                         8 months 12 days            
Potential share-based compensation expense.                                           700                
Exercisable (in shares)         1,061 772                                                
Expected to vest (net of expected forfeitures) (in shares)         660 602                                                
Aggregate Intrinsic value, outstanding         8,367 7,757                                                
Aggregate Intrinsic value, exercisable         7,213 4,819                                                
Aggregate Intrinsic value, expected to vest         $ 1,085 $ 2,732                                                
Number of Shares                                                            
Granted (in shares)                                               18            
Units outstanding at the end of the period (in shares)                                             18 18            
Weighted Average Grant Date Fair Value                                                            
Granted (in dollars per share)                                               $ 12.07            
Units outstanding at the end of the period (in dollars per share)                                             $ 12.07 $ 12.07